Imperial College London
Alternate

Professor Irene Roberts

Faculty of Medicine, Department of Immunology and Inflammation

Visiting Professor
 
 
 
//

Contact

 

+44 (0)20 3313 2163irene.roberts

 
 
//

Assistant

 

Miss Karen Linfield +44 (0)20 3313 3238

 
//

Location

 

4S10BHammersmith HospitalHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Innes:2013:10.1038/bmt.2013.69,
author = {Innes, AJ and Beattie, R and Sergeant, R and Damaj, G and Foroni, L and Marin, D and Kanfer, E and Mielke, S and Milojkovic, D and MacDonald, D and Pavlu, J and Rahemtulla, A and Roberts, I and Slade, D and Bray, E and Goldman, J and Apperley, J and Szydlo, R and Dazzi, F and Rezvani, K},
doi = {10.1038/bmt.2013.69},
journal = {BONE MARROW TRANSPLANTATION},
pages = {1324--1328},
title = {Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT},
url = {http://dx.doi.org/10.1038/bmt.2013.69},
volume = {48},
year = {2013}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Innes,AJ
AU  - Beattie,R
AU  - Sergeant,R
AU  - Damaj,G
AU  - Foroni,L
AU  - Marin,D
AU  - Kanfer,E
AU  - Mielke,S
AU  - Milojkovic,D
AU  - MacDonald,D
AU  - Pavlu,J
AU  - Rahemtulla,A
AU  - Roberts,I
AU  - Slade,D
AU  - Bray,E
AU  - Goldman,J
AU  - Apperley,J
AU  - Szydlo,R
AU  - Dazzi,F
AU  - Rezvani,K
DO  - 10.1038/bmt.2013.69
EP  - 1328
PY  - 2013///
SN  - 0268-3369
SP  - 1324
TI  - Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT
T2  - BONE MARROW TRANSPLANTATION
UR  - http://dx.doi.org/10.1038/bmt.2013.69
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325643700011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL  - 48
ER  -
Download